Hydroxymethyl pyrrolidines as β3 adrenergic receptor agonists

The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.

Saved in:
Bibliographic Details
Main Authors Berger, Richard, Chang, Lehua, Edmondson, Scott D, Goble, Stephen D, Ha, Sookhee Nicole, Kar, Nam Fung, Kopka, Ihor E, Li, Bing, Morriello, Gregori J, Moyes, Chris R, Shen, Dong-Ming, Wang, Liping, Zhu, Cheng
Format Patent
LanguageEnglish
Published 21.08.2012
Online AccessGet full text

Cover

More Information
Summary:The present invention provides compounds of Formula (I), pharmaceutical compositions thereof, and method of using the same in the treatment or prevention of diseases mediated by the activation of β3-adrenoceptor.